7. Bayer settles most Essure claims for $1.6B

[Image from Unsplash]
The Essure agreement was part of a host of legal settlements as corporate leaders decided it was better to resolve legal disputes rather than risk more money contesting them amid the COVID-19 pandemic and resulting recession.
Abbott and Edwards Lifesciences agreed in July to settle all outstanding patent disputes related to transcatheter mitral and tricuspid repair products, with Edwards paying Abbott $368 million. https://www.massdevice.com/breaking-abbott-edwards-settle-heart-device-patent-spats/
Also in July, Medtronic and Tandem Diabetes Care announced that they’d inked a non-exclusive, patent cross-license agreement related to diabetes treatment tech.The companies said the agreement will allow them to focus on innovation while avoiding the distraction of potential legal disagreements. – CN